• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CDC - Live phone conference/webinar June 13 : 2-3 pm EST - Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Information and Guidance for Clini

sharon sanders

Editor-in-Chief & President
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Information and Guidance for Clinicians

CE.gif
= No Continuing Education
Date: Thursday, June 13, 2013
Time: 2:00 - 3:00 pm (Eastern Time)
Join by Phone:
Dial: 888-469-1678
Passcode:
3109821
Join by Webinar: https://www.mymeetings.com/nc/join.php?i=PW1088072&p=3109821&t=c
Presenter(s):

CCT_v3_Square_60x62.gif

Susan Gerber, MD
Medical Epidemiologist
Division of Viral Diseases
National Center for Immunization and Respiratory Disease
Centers for Disease Control and Prevention


CCT_v3_Square_60x62.gif

Alexander Kallen, MD, MPH
Medical Officer
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Overview:

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a newly identified virus that can cause severe acute respiratory illness and death. MERS cases have been linked to the Middle East, and there is documented spread of the virus internationally. So far, no cases of MERS have been reported in the United States. However, clinicians need to remain vigilant. Epidemiologic investigations have demonstrated that this unique virus spreads from person to person during close contact, such as within families and healthcare facilities. Clinicians have a critical role in recognizing and managing suspect cases of MERS. During this COCA call, a CDC subject matter expert will discuss the clinical signs, epidemiology and infection control recommendations for MERS-CoV.
Objectives:

At the conclusion of the session, the participant will be able to accomplish the following:

  • Describe the key components in the surveillance case definition for a patient under investigation for MERS-CoV infection
  • Identify specimens to be obtained and the appropriate laboratory test to diagnose a patient with MERS-CoV infection
  • List infection control measures appropriate for control of MERS-CoV
CDC Medscape Commentary

Be on the Alert for This Novel Coronavirus

Additional Resources:

MERS


Planning



<table class="table" summary="Conference Call Requirements" border="0" cellpadding="2" cellspacing="0"> <tbody><tr> <th scope="row" align="left" valign="top"> HARDWARE/SOFTWARE

Minimum System Requirements
</th> <td align="left" valign="top">
  • Windows XP Professional with Service Pack 3
  • Microsoft Office Live Meeting
  • 512 megabytes (MB) of RAM - 1 GB Recommended
  • Data and voice: 1 gigahertz (GHz) or faster processor, Intel Pentium-compatible
  • High-speed Internet connection
  • Super VGA 1024x768 or higher
  • Video card with 64 MB of RAM (video RAM or VRAM) and Microsoft DirectX? 9 application programming interface generation
</td> </tr> <tr> <th scope="row" align="left" valign="top"> ACTIVITY NUMBER
</th> <td align="left" valign="top">EC/PD/WD 1648</td> </tr> <tr> <th scope="row" align="left" valign="top"> DATE OF ORIGINATION
</th> <td align="left" valign="top">NOV 1, 2007</td> </tr> <tr> <th scope="row" align="left" valign="top"> DATE OF RENEWAL
</th> <td align="left" valign="top">DEC 18, 2011</td> </tr> <tr> <th scope="row" align="left" valign="top"> DATE OF EXPIRATION
</th> <td align="left" valign="top">DEC 18, 2013</td> </tr> <tr> <th scope="row" align="left" valign="top"> MATERIALS
</th> <td align="left" valign="top">PowerPoint Slide Set</td> </tr> <tr> <th scope="row" align="left" valign="top"> TARGET AUDIENCE
</th> <td align="left" valign="top">Physicians, Nurses, Pharmacists, Veterinarians, Physician Assistants, and Other Clinicians
</td> </tr> <tr> <th scope="row" align="left" valign="top"> PREREQUISITES
</th> <td align="left" valign="top">None</td> </tr> <tr> <th scope="row" align="left" valign="top"> FORMAT
</th> <td align="left" valign="top">Live audio conference call on 6/13/13: 2:00 - 3:00 PM
Audio-on-demand training after 3:00 PM on 6/13/13
</td> </tr> <tr> <th scope="row" align="left" valign="top"> CONTACT INFORMATION
</th> <td align="left" valign="top">coca@cdc.gov</td> </tr> <tr> <th scope="row" align="left" valign="top"> SUPPORT/FUNDING
</th> <td align="left" valign="top">Centers for Disease Control and Prevention, Emergency Risk Communications Branch
</td> </tr> <tr> <th scope="row" align="left" valign="top"> METHOD OF PARTICIPATION
</th> <td align="left" valign="top">Attend the live conference call/webinar or download the materials afterwards
</td> </tr> <tr> <th scope="row" align="left" valign="top"> FEES
</th> <td align="left" valign="top">There is no charge for COCA continuing education
</td> </tr> </tbody></table>
Accreditation Statements:

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME?) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this electronic conference/web-on-demand educational activity for a maximum of 1.0 AMA PRA Category 1 Credit?. Physicians should only claim credit commensurate with the extent of their participation in the activity. Non-physicians will receive a certificate of participation.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides1.0 contact hour.
CEU: The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer1.0ANSI/IACET CEU for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) to receive up to 1.0 Category I CECH in health education. CDC provider number GA0082.
ACPE.jpg
ACPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-13-008-L04-P and enduring 0387-0000-13-008-H04-P. Course Category: This activity has NOTbeen designated as Knowledge-Based.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.2 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB Race Program at race@aavsb.org if you have any comments/concerns regarding this program?s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, and the presenters for this seminar do not have financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. This presentation does not involve the unlabeled use of a product or product under investigational use. There is no commercial support for this activity.
To earn continuing education/contact hours:


  1. Go to the CDC Training & Continuing Education Online System.
  2. Log in as a participant. If this is your first visit, you will need to register and establish a login name and password.
  3. Click on Search and Register.
  4. Under ?keyword search? find the course you are interested in by entering:
    • ?EC1648? for calls hosted in last 30 days
    • ?WD1648? for calls hosted past 30 days
  5. Select your course.
  6. CE certificates can be printed immediately upon completion of your online evaluation.
If you cannot participate in the live COCA Conference Call, you can still get continuing education/contact hours


  1. Download the PowerPoint or webinar.
  2. Complete the on-line evaluation within a year (and follow the instructions above.)
  3. CE certificates can be printed immediately upon completion of your online evaluation.


http://emergency.cdc.gov/coca/calls/2013/callinfo_061313.asp
 
Re: CDC - Live phone conference/webinar today 2-3 pm EST - Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Information and Guidance for Clinicians

Re: CDC - Live phone conference/webinar today 2-3 pm EST - Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Information and Guidance for Clinicians

My notes:

@CDCgov - COCA Call #nCoV #Coronavirus Information and Guidance for Clinicians - Now Starting #fb

Susan Gerber, MD & Alexander Kallen, MD, MPH will be making presentation #nCoV #coronavirus @CDCgov #fb

@CDCgov #coronavirus #nCoV site: http://www.cdc.gov/coronavirus/ #fb

Media calls are not allowed in this conference - clinicians only @CDCgov #nCoV #coronavirus #fb

Gerber: 6 human coronaviruses identified to date. #nCoV is a beta coronavirus @cdcgov #coronavirus #fb

Gerber: #nCoV - On 3rd day of illness in 1st patient from 2012 creatinine levels were elevated. #coronavirus @CDCgov #fb

Gerber: #nCoV most closely related to 2 bat viruses - 1st cluster retro identified from #Jordan 4/12 @CDCgov #coronavirus #fb

Gerber: Now describing a #Saudi cluster. Diarrhea first symptom. @CDCgov #nCoV #coronavirus #fb

Gerber: Referencing initial #Jordan cluster. We have here: http://www.flutrackers.com/forum/showthread.php?t=185880 ? #nCoV #coronavirus @CDCgov

Gerber: Describing initial imported #UK case cluster. 1-9 days is incubation period. Possible H2H trans. @CDCgov #nCoV #coronavirus #fb

Gerber: #France cluster description. Nosocomial transmission. 9-12 days incubation period. #nCoV #coronavirus @CDCgov #fb

Gerber:Average age n Al-Ahsa #Saudi cases is 56. Most w/comorbitiies. Several kinds of transmission indicated @CDCgov #nCoV #coronavirus #fb

Gerber: Now describing CDC case definition. Updated here: http://www.cdc.gov/coronavirus/mers/case-def.html ? #nCoV #coronavirus @CDCgov #fb

Kallen: Recommend standard infection controls 4 hospitalized #nCoV - Updated June 11 here: http://www.cdc.gov/coronavirus/mers/interim-recommendations-patients-2013.html ? @CDCgov #coronavirus #fb

Kallen: N95 + masks and PPE s/b used in #nCoV #coronavirus situations. Dispose of according to manufacture guidelines @CDCgov #fb

Gerber: Interim Guidelines for Collection, Processing &Transport of Clinical Specimens http://www.cdc.gov/coronavirus/mers...ines-MERS-Collection-Processing-Transport.pdf ? @CDCgov #nCoV #coronavirus #fb

Gerber:Currently treatment is supportive. No antivirals identified.Approx 50% mortality rate. No cases n #USA @CDCgov #nCoV #coronavirus #fb

Gerber: Important to find cases to employ spread prevention protocols. Need to identify animal host. @CDCgov #nCoV #coronavirus #fb

Gerber: Do not hesitate to test for suspected #nCoV #coronavirus in patients that present with symptoms @CDCgov #nCoV #coronavirus #fb

Gerber: Comorbidities in cases seen so far include cancer and kidney problems. #nCoV #coronavirus @CDCgov #fb

Gerber: Specimens from both upper and lower respiratory system have tested positive for #nCoV #coronavirus @cdcgov #fb

Gerber:There may b unusual symptoms like diarrhea n this basically respiratory illness-patients w/comorbidity @CDCgov #nCoV #coronavirus #fb

Gerber:: No information about possible positive cases who are asymptomatic . @CDCgov #nCoV #coronavirus #fb

Gerber: Blood bank safety? 1-12 days incubation period - need more info. Limited info on transmission period. #nCov #coronavirus @CDCgov #fb

Moderator announces slides now available here: http://emergency.cdc.gov/coca/ppt/2013/06_13_13_MERSCoV_FINAL.pdf ? #nCov #coronavirus @CDCgov #fb

Gerber: Large variance n exposures n various clusters:1-12 days:data always updated-ck frequently http://www.cdc.gov/coronavirus/ @CDCgov #nCoV #fb

Gerber: Assays are becoming more widely available throughout US. #nCoV #coronavirus @CDCgov #fb

Gerber: @CDCgov is assisting with inquiries about suspected cases but so far none have tested positive in the US. #nCoV #coronavirus #fb

COCA conference is over. #nCoV #coronavirus @CDCgov #fb
 
Back
Top Bottom